RxDoctor Payments DataLook up a doctor →

Kathleen Corey, MD

Gastroenterology · Boston, MANPI 1326174038

Payments from drug & device makers

$1,375,056in general payments, 2019–2025

Across 278 payments — averaging $4946.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$801K
  • Intercept Pharmaceuticals, Inc.$200K
  • Theratechnologies Inc.$150K
  • Intercept Pharma Europe Ltd.$91K
  • Novo Nordisk AS$77K
  • Gilead$16K
  • plus $41K from 7 others

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,375,056 in reported general payments places this provider in the 95th percentile of 579 gastroenterology providers in Massachusetts.

See all gastroenterology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$44,460
Medicare patients
182
Services billed
366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →